This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: Merrell Pharmaceuticals, Inc., Hoechst Marion Roussel. Active years: 2000-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000-2002
Title: Mark G Eller: Innovator in Antihistaminic Treatments
Introduction
Mark G Eller is a notable inventor based in Overland Park, Kansas. He has made significant contributions to the field of pharmaceuticals, particularly in developing methods for providing antihistaminic effects in patients with hepatic impairment. With a total of 3 patents to his name, his work has had a meaningful impact on medical treatments.
Latest Patents
Among his latest patents is a method specifically designed for providing an antihistaminic effect in a hepatically impaired patient. This innovative approach involves administering an effective antihistaminic amount of a compound formulated to cater to the unique needs of such patients. This invention showcases his commitment to improving patient care and treatment efficacy.
Career Highlights
Throughout his career, Mark G Eller has worked with reputable companies in the pharmaceutical industry. Notably, he has been associated with Merrell Pharmaceuticals, Inc. and Hoechst Marion Roussel. His experience in these organizations has undoubtedly contributed to his expertise and innovative capabilities in the field.
Collaborations
Mark has collaborated with several professionals in his field, including James K Woodward and Richard A Okerholm. These partnerships have likely enriched his work and led to further advancements in his research and inventions.
Conclusion
Mark G Eller stands out as a dedicated inventor whose work in antihistaminic treatments has the potential to improve the quality of life for many patients. His contributions to the pharmaceutical industry reflect his innovative spirit and commitment to healthcare advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile